CAS: 1346452-25-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Enfortumab vedotin-ejfv REF: TM-T78065CAS: 1346452-25-2 | - - - | 790.00 €~6,230.00 € | Fri 09 Aug 24 | |
Enfortumab REF: 3D-CLA1341CAS: 1346452-25-2 | - - - | 1,121.00 €~6,371.00 € | Fri 13 Sep 24 |
Enfortumab vedotin-ejfv
CAS:1346452-25-2
Enfortumab vedotin-ejfv is an antibody-drug conjugate targeting Nectin-4, employed in the treatment of urothelial carcinoma …
Color and Shape:
Solid
Ref: TM-T78065
1mg | 790.00 € | ||
5mg | 2,297.00 € | ||
10mg | 3,110.00 € | ||
25mg | 4,613.00 € | ||
50mg | 6,230.00 € |
Estimated delivery in United States, on Friday 9 Aug 2024
Ref: 3D-CLA1341
1mg | 1,121.00 € | ||
5mg | 2,272.00 € | ||
10mg | 3,386.00 € | ||
25mg | 4,277.00 € | ||
50mg | 6,371.00 € |
Estimated delivery in United States, on Friday 13 Sep 2024